Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Immunoblotting of phospho-Rb Protein lysates were processed following standard procedures and analysed by SDS-PAGE followed by immunoblotting
A pre-treatment health assessment is essential
Tesamorelin Peptide Regulatory Status in Canada Health Canada Approval Status (Egrifta and Egrifta SV) Tesamorelin is the active ingredient in Egrifta, an approved prescription drug product authorized by Health Canada under a Notice of Compliance issued April 29, 2014, to Theratechnologies Inc
10.1007/s11270-015-2624-y Summary Keywords nanohydrogels, natural protein, biodegradability, drug delivery, self-assembly, polymeric networks Citation Chander S, Kulkarni GT, Dhiman N and Kharkwal H (2021) Protein-Based Nanohydrogels for Bioactive Delivery
US$ 20.12
US$ 24.52
US$ 20.03
US$ 21.94
US$ 20.41
US$ 20.18
US$ 25.32
